MBCI Net Margin

The Net Margin of MabCure Inc (MBCI) is -2452.97%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

MBCI Net Margin - Historical Value

Date	Value
2011-12-31	-2452.97%

MBCI Net Margin - Peers Comparison

Ticker	Name	Value
CXBS	Corix Bioscience Inc	-638.63%
NNBP	Nanobac Pharmaceuticals Inc	-36527.78%
VIAP	VIA Pharmaceuticals Inc	-23778.31%
BGES	Bio-Bridge Science Inc	-5020.00%
CLBS	Caladrius Biosciences Inc	-359.67%
PPMD	Protide Pharmaceuticals Inc	-19.25%
PROT	Stromacel Inc	-5322.50%
GOSS	Gossamer Bio Inc	-49.28%
HSTC	HST Global Inc	-6.47%
KRTX	Karuna Therapeutics Inc	-66311.93%
PARD	Poniard Pharmaceuticals Inc	-139980.00%
PLPL	Plandai Biotechnology Inc	-1467.09%
ENDV	Endonovo Therapeutics Inc	-13648.67%
PANC	Panacos Pharmaceuticals Inc	-20810.56%
ZIOP	ZIOPHARM Oncology Inc	-35413.30%
BSSP	Baseline Productions Inc	-402.83%
FPMI	FluoroPharma Medical Inc	-11.76%